NCT00187720View on ClinicalTrials.gov

Genetic Basis for Variation in the Renal Elimination of Metformin

PHASE4CompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

May 31, 2002

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Other Conditions That May Be A Focus of Clinical Attention
Interventions
DRUG

Metformin

Subjects will be given a single oral dose of 850 mg of metformin

Trial Locations (1)

94143

San Francisco General Hospital, San Francisco

All Listed Sponsors
lead

University of California, San Francisco

OTHER

NCT00187720 - Genetic Basis for Variation in the Renal Elimination of Metformin | Biotech Hunter | Biotech Hunter